Table 1 Clinicopathological features and NSUN2 in GC.
From: NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation
Variables | All patients (n = 402) | Low (n = 369) | High (n = 33) | P value |
|---|---|---|---|---|
Gender | 0.010* | |||
Female | 95 | 93 | 2 | |
Male | 307 | 276 | 31 | |
Age | 0.522 | |||
<65 | 192 | 178 | 14 | |
≥65 | 210 | 191 | 19 | |
T stage | 0.621 | |||
T1 + T2 | 125 | 116 | 9 | |
T3 + T4 | 277 | 253 | 24 | |
N stage | 0.570 | |||
N0 + N1 | 238 | 220 | 18 | |
N2 + N3 | 164 | 149 | 15 | |
Tumor size | 0.643 | |||
<4.5 cm | 253 | 231 | 22 | |
≥4.5 cm | 149 | 138 | 11 | |
Stage | 0.522 | |||
I + II | 192 | 178 | 14 | |
III + IV | 210 | 191 | 19 | |
Differentiation | ||||
Moderate + Well | 124 | 113 | 11 | 0.747 |
Poor | 278 | 256 | 22 |
